Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease
Cernibori
Rivista di Neurologia 40(5): 303-309
1970
ISSN/ISBN: 0035-6344 PMID: 5503723 Document Number: 26427
Document emailed within 1 workday
Related Documents
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality Bmj 317(7172): 1586-1587
Counsell, C. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required Bmj 317(7172): 1586
Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Vajda, F.J.; Donnan, G.A.; Bladin, P.F. 1978: Patterns of response to levodopa in Parkinson's disease Clinical and Experimental Neurology 15: 299-306
Larsen, J.P.; Nessler, E.G.; Hestnes, A.; Vilming, S.; Holmsen, R.; Aksnes, V.; Johnson, S.; Brodtkorb, E.; Hunstad, N.A.; Helle, J.R. 1991: Treatment of Parkinson disease with levodopa depot preparations Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3163-3166
Rudakova, A.V.; Yakupov, E.Z. 2014: Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 117-121
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Houeto, J.L.; Mesnage, V.; Welter, M.L.; Mallet, L.; Agid, Y.; Bejjani, B.P. 2003: Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up Neurology 60(1): 154-5; Author Reply 154-5
Slaoui, T.; Mas-Gerdelat, A.; Ory-Magne, F.; Rascol, O.; Brefel-Courbon, C. 2007: Levodopa modifies pain thresholds in Parkinson's disease patients Revue Neurologique (Paris) 163(1): 66-71
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Singer, E. 1976: Sociopsychological factors influencing response to levodopa therapy for Parkinson's disease Archives of Physical Medicine and Rehabilitation 57(1): 328-334
Liashchenko, E.A.; Skripkina, N.A.; Levin, O.S. 2013: Influence of levodopa, stalevo on dyskinesia in Parkinson's disease: STRIDE-PD study Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 62-68
Terashima, S.; Yanagido, Y.; Watabe, A.; Yamane, M.; Morimoto, Y. 2015: Perioperative Management of a Patient with Severe Parkinson's Disease with Intravenous Levodopa Administration Masui. Japanese Journal of Anesthesiology 64(8): 845-848
Obeso, J.A.; Rodriguez-Oroz, M.C.; Rodriguez, M.; DeLong, M.R.; Olanow, C.W. 2000: Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model Annals of Neurology 47(4 Suppl 1): S22
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302